Skip to main navigation Skip to main content
Psychology
Phone:
(023) 8059 5577
Email:
Samuele.Cortese@soton.ac.uk

Professor Samuele Cortese M.D., PhD.

Professor of Child and Adolescent Psychiatry

Professor Samuele Cortese's photo

Samuele Cortese is Professor of Child and Adolescent Psychiatry within Psychology and Medicine at the University of Southampton.

1999: M.D. (summa cum laude), Verona University, Verona, Italy

2004: Specialty in Child Neuropsychiatry (summa cum laude), Verona University, Verona, Italy (equivalent CCT in child and adolescent psychiatry obtained by the GMC on 27.07.12)

2005-2006: Clinical Research Assistant, Child and Adolescent Psychopathology Unit, Robert Debré Hospital, Paris VII University, Paris, France

2006-2008: Chef de Clinique, Child and Adolescent Psychopathology Unit, Robert Debré Hospital, Paris VII University, Paris, France

2009: PhD. in Multimodal Imaging in Biomedicine, Verona University, Verona, Italy. Given the fulfilment of the prerequisites proposed by the European University Association (1992), I was awarded with the additional label of “DOCTOR EUROPAEUS”.

2009: Research Associate, Child Neuropsychiatry Unit, Mother-Child and Biology-Genetics Department, Verona University, Verona, Italy

2010: Assistant Professor, Tours University, France

2010-2013: Marie Curie Post-Doctoral Fellow (International Outgoing Fellowship for Carer Development), Institute for Pediatric Neuroscience, New York University Child Study Center, NYC, NY, USA & Department of Life and Reproduction Sciences, Verona University, Verona, Italy

2014 onwards: Honorary Clinical Associate Professor of Child Psychiatry, University of Nottingham, UK

2014 to date: Adjunct Associate Professor of Child Psychiatry, New York University, NY, USA

2015 onwards: Honorary Consultant in Child and Adolescent Psychiatry, Solent NHS Trust

2015-2019: Clinical Associate Professor, University of Southampton

2019 onwards: Professor of Child and Adolescent Psychiatry, University of Southampton

Research interests

My research aims to inform clinical decision making in child and adolescent psychiatry, with a specific focus on ADHD (and its related neurodevelopmental conditions), and sleep disorders. My studies are mainly based on advanced meta-analytic approaches, as well as large epidemiological datasets.

In 2020, I was included in the list of the world's most influential researchers of the past decade, demonstrated by the production of multiple highly-cited papers that rank in the top 1% by citations in the field of psychiatry/psychology in 2019 in Web of Science . In 2021 I also ranked #1 worldwide in terms of expertise on Attention-Deficit/Hyperactivity Disorder (ADHD) and #2 in child mental health according to Expertscape .

Network of research collaborations

Network of research collaborations
Network of research collaborations

COH

Since 2020, I am the coordinator for the UK of the world’s largest survey on the mental and physical corelates of the Covid-19 pandemic, Collaborative Outcomes study on Health and Functioning during Infection Times ( COH-FIT ).

The study is based on an ANONYMOUS survey open to everyone aged 6 or more. It is available in 30 languages and it takes about 30 minutes for adults and 20 for children/adolescents.

Please help us understand the physical and mental impact of the Covid-19 pandemic by completing the survey here .

Research projects

Comparative efficacy and  pharmacological and non-pharmacological treatments

Association between mental disorders and somatic conditions (AMASU project)

Sleep disorders in children with neurodevelopmental disorders

Prevalence of neurodevelopmental disorders

OPTIMA: On-Line Parent Training for the Initial Management of ADHD referral

Effects of external Trigeminal Nerve Stimulation in ADHD and mechanisms of action

Stimulant Medication for ADHD and Tics - Understanding Response versus Non-stimulants (SATURN study): a randomised trial of the clinical and cost-effectiveness of methylphenidate versus guanfacine for ADHD in children and young people with a co-existing tic disorder

Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT)

ACTIVE GRANTS

NIHR (PgfAR) Digital Sleep Support for Children with AttentionDeficit/Hyperactivity Disorder (The DISCA study)- 2022-2028. £2.280.000,00. Joint Lead

NIHR (RfPB))Comparing pharmacological and non-pharmacological interventions for adults with Attention-Deficit/Hyperactivity Disorder (ADHD): systematic review and network meta-analysis -2022-2025. £149.400,00. Lead

NIHR (EME) Effects of external Trigeminal Nerve Stimulation in ADHD and mechanisms of action (ATTENS). 2021-2025. £1,911,504.82. Co-I

NIHR ARC Wessex. 2021-2015. £ 749,843 (total). Co-lead in Healthy Community team

NIHR (HTA) Stimulant Medication for ADHD and Tics – Understanding Response versus Non-stimulants (SATURN study): a randomised trial of the clinical and costeffectiveness of methylphenidate versus guanfacine for ADHD in children and young people with a co-existing tic disorder (Saturn). 2021-2025. £ 1,628,868.50. Co-I.

NIHR (PgfAR) On-Line Parent Training for the Initial Management of ADHD referral (OPTIMA)- RP-PG-0618- 20003. 2021-2025. £1,957,977.00. Co-I

Solent NHS Trust, Research Capability Funding (NIHR Funding). 2021-2022. £ 17,300. Lead

Research group

Centre for Innovation in Mental Health (CiMH)

Research project(s)

On-Line Parent Training for the Initial Management of ADHD referral (OPTIMA)

Medication for ADHD in children and young people with a co-existing tic disorder (SATURN)

Comparative Efficacy and Tolerability of ADHD Medications

Sleep Disturbances in Individuals with Neurodevelopmental Disorders

The project included a series of meta-analyses in children. adolescents, adults with ADHD, ASD and other neurodevelopmental disorders to quantify the association between neurodevelopmental disorders and subjective as well as objective alterations of sleep.

Local roles:

  • Member of the Ethic Committee Reviewers group (2016-2020)
  • Member of the Committee of the Southern branch of the Association for Child and Adolescent Mental Health (ACAMH)

National roles:

  • Branch Liaison Officer of the Association for Child and Adolescent Mental Health (ACAMH) (2016-2020)
  • Academic Secretary of the Association for Child and Adolescent Mental Health (ACAMH)
  • Member of the Board of the Association for Child and Adolescent Mental Health (ACAMH)
  • Member of the Child Psychiatry Research Society
  • Member of the British Association of Psychopharmacology (BAP) child and adolescent module faculty

International roles:

  • Member of the European ADHD Guidelines Group (EAGG)
  • Member elected of the Steering Committee of the European Network for Hyperkinetic Disorders (Eunethydis)
  • Member of the Child and Adolescent network of the European College of Neurosychopharmacology (ECNP)
  • Member of the Guidelines group of the Canadian ADHD Resource Alliance (CADDRA)

Editorial roles:

  • Deputy Editor for the Journal of the American Academy of Child and Adolescent Psychiatry
  • Deputy Editor of Evidence Based Mental Health (BMJ Group)
  • Associate Editor of Child and Adolescent Mental Health (CAMH)
  • Member of the Advisory Board of the Journal of Child Psychology and Psychiatry and allied disciplines
  • Member of the Editorial Board of CNS Drugs
  • Member of the Editorial Board of the Journal of Child and Adolescent Psychopharmacology
Professor Samuele Cortese
Samuele.Cortese@soton.ac.uk
Contact number: 023 8059 5577 (extension 25577)

Room Number : 44/4059

Privacy Settings